LEATCRT-G2
Live / Registered — Registered (as of 04 Jul 2023)
What this means for you
Registered since 04 Jul 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97437065
- Registration number
- 7100508
- Mark type
- Stylized text
- Filed
- 31 May 2022
- Published for opposition
- 18 Apr 2023
- Registered
- 04 Jul 2023
Goods and services
- Class 005 — Pharmaceuticals: Immunostimulants; Biological preparations for the treatment of cancer; Disinfecting wipes; First aid kits; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Tumor suppressing agents
Owner
- Liling biopharmaceuticals (Suzhou) Co., Ltd, Jiangsu, CN
- Liling biopharmaceuticals (Suzhou) Co., Ltd, Jiangsu, CN
- Liling biopharmaceuticals (Suzhou) Co., Ltd, Jiangsu, CN
Prosecution history
- 11 Jan 2025 — WITHDRAWAL OF ATTORNEY GRANTED
- 11 Jan 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
- 04 Jul 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Jul 2023 — REGISTERED-PRINCIPAL REGISTER
- 18 Apr 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Apr 2023 — PUBLISHED FOR OPPOSITION
- 29 Mar 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Mar 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Mar 2023 — ASSIGNED TO EXAMINER
- 08 Jun 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 03 Jun 2022 — NEW APPLICATION ENTERED